| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| S K Ray, M K Podda. Interaction of central serotonin and dopamine in the regulation of carbaryl-induced tremor. European journal of pharmacology. vol 181. issue 3. 1990-09-18. PMID:1696544. |
interaction of central serotonin and dopamine in the regulation of carbaryl-induced tremor. |
1990-09-18 |
2023-08-11 |
rat |
| L G Miller, J Jankovi. Neurologic approach to drug-induced movement disorders: a study of 125 patients. Southern medical journal. vol 83. issue 5. 1990-06-26. PMID:1971459. |
of 125 patients with neuroleptic (dopamine blocking) drug-induced movement disorders who had been referred to a specialized clinic to differentiate the predominant movement disorder, 63% had tardive dyskinesia, 30% had parkinsonism, 24% had dystonia, 7% had akathisia, and 2% had isolated tremor. |
1990-06-26 |
2023-08-11 |
Not clear |
| W C Koller, B Vetere-Overfield, R Barte. Tremors in early Parkinson's disease. Clinical neuropharmacology. vol 12. issue 4. 1989-11-30. PMID:2804993. |
the dopamine agonist naxoglide (phno) reduced resting tremor in 77% and postural tremor in 70% of patients. |
1989-11-30 |
2023-08-11 |
Not clear |
| M Goldstei. Monkeys with unilateral ventromedial tegmental lesions of the brain stem: models for Parkinson's disease and Lesch-Nyhan syndrome. Progress in neuro-psychopharmacology & biological psychiatry. vol 13. issue 3-4. 1989-08-21. PMID:2501825. |
in monkeys with unilateral ventrolateral tegmental lesions, the levels of dopamine and the activities of catecholamine-synthesizing enzymes were reduced on the lesion side of the striatum, and hypokinesia and tremor developed on the contralateral extremities. |
1989-08-21 |
2023-08-11 |
monkey |
| M Goldstei. Monkeys with unilateral ventromedial tegmental lesions of the brain stem: models for Parkinson's disease and Lesch-Nyhan syndrome. Progress in neuro-psychopharmacology & biological psychiatry. vol 13. issue 3-4. 1989-08-21. PMID:2501825. |
dopa or dopamine agonists relieve tremor and evoke abnormal involuntary movements which are similar to the responses observed in patients with parkinson's disease. |
1989-08-21 |
2023-08-11 |
monkey |
| D W Herr, H A Tilso. Modulation of p,p'-DDT-induced tremor by catecholaminergic agents. Toxicology and applied pharmacology. vol 91. issue 2. 1987-12-11. PMID:3672520. |
dopamine and beta receptors may be involved in the tonic inhibition of tremor produced by ddt. |
1987-12-11 |
2023-08-11 |
human |
| G J de Jong, J D Meerwaldt, P I Schmit. Factors that influence the occurrence of response variations in Parkinson's disease. Annals of neurology. vol 22. issue 1. 1987-09-30. PMID:3631919. |
retrospective study of 129 patients treated with dopamine substitution showed that the occurrence of response variations is related to the duration of therapy and not to the nature of the predominant symptom (tremor or hypokinesia and rigidity) or the age of onset of the disease. |
1987-09-30 |
2023-08-11 |
Not clear |
| J S Hong, D W Herr, P M Hudson, H A Tilso. Neurochemical effects of DDT in rat brain in vivo. Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement. vol 9. 1987-03-13. PMID:2434059. |
there is a good correlation between ddt-induced tremor and an increase in the levels of the metabolites of norepinephrine (ne), serotonin (5ht) and, to a lesser extent, dopamine (da) in the brain stem (bs), hypothalamus (hyp), striatum (str), or hippocampus (hpc). |
1987-03-13 |
2023-08-11 |
rat |
| W Schult. Recent physiological and pathophysiological aspects of Parkinsonian movement disorders. Life sciences. vol 34. issue 23. 1984-07-13. PMID:6374348. |
in animal models, parkinsonian-like hypokinesia is consistently reproduced with large nigrostriatal dopamine depletions, while tremor and rigidity are less readily obtained. |
1984-07-13 |
2023-08-12 |
monkey |
| S L Dickinson, P Slate. Effect of lesioning dopamine, noradrenaline and 5-hydroxytryptamine pathways on tremorine-induced tremor and rigidity. Neuropharmacology. vol 21. issue 8. 1982-12-02. PMID:7121751. |
effect of lesioning dopamine, noradrenaline and 5-hydroxytryptamine pathways on tremorine-induced tremor and rigidity. |
1982-12-02 |
2023-08-12 |
rat |
| G W Kraemer, G R Breese, A J Prange, E C Moran, J K Lewis, J W Kemnitz, P J Bushnell, J L Howard, W T McKinne. Use of 6-hydroxydopamine to deplete brain catecholamines in the rhesus monkey: effects on urinary catecholamine metabolites and behavior. Psychopharmacology. vol 73. issue 1. 1981-07-20. PMID:6785782. |
subjects with the largest depletions of brain dopamine (da) (greater than 90%) were hypokinetic, rigid, and had a distal limb tremor. |
1981-07-20 |
2023-08-12 |
human |
| D M Coward, N S Dogget. Potentiation of LON 954 tremor by typical and atypical neuroleptics--an indication of striatal dopamine antagonism. Psychopharmacology. vol 67. issue 2. 1980-06-27. PMID:6102779. |
potentiation of lon 954 tremor by typical and atypical neuroleptics--an indication of striatal dopamine antagonism. |
1980-06-27 |
2023-08-12 |
mouse |
| W C Bowman, M W Not. Peripheral muscle effects of levodopa in the anesthetized cat. Clinical and experimental pharmacology & physiology. vol 5. issue 4. 1978-12-20. PMID:699376. |
these results therefore suggest that levodopa, via its decarboxylated metabolites, dopamine, noradrenaline and adrenaline, may produce or exacerabate tremor in man. |
1978-12-20 |
2023-08-11 |
human |
| M M Hoehn, T J Crowley, C O Rutledg. The Parkinsonian syndrome and its dopamine correlates. Advances in experimental medicine and biology. vol 90. 1978-01-27. PMID:930745. |
in neither study was there a significant correlation between free urinary dopamine and tremor. |
1978-01-27 |
2023-08-11 |
Not clear |
| D M Coward, N S Dogget. The production of an alternative laboratory model of the Parkinson syndrome using a new benzylimidoylurea derivative LON 954. Psychopharmacology. vol 52. issue 2. 1977-09-22. PMID:407600. |
this tremor can be antagonised by the dopamine receptor agonists l-dopa, bromocriptine, nomifensine and piribedil, as well as by anticholinergic anti-parkinson drugs having an inhibitory effect on dopamine uptake such as benapryzine and benztropine. |
1977-09-22 |
2023-08-11 |
mouse |
| N S Doggett, S A O'Farrel. Modification of oxotremorine tremor and hypothermia by injections of drugs into the cerebral ventricles of the mouse. Naunyn-Schmiedeberg's archives of pharmacology. vol 294. issue 2. 1977-03-21. PMID:1012335. |
dopamine and apomorphine (0.1-10 mug) had no significant effect on oxotremorine tremor. |
1977-03-21 |
2023-08-11 |
mouse |
| M M Hoehn, T J Crowley, C O Rutledg. Dopamine correlates of neurological and psychological status in untreated Parkinsonism. Journal of neurology, neurosurgery, and psychiatry. vol 39. issue 10. 1977-02-16. PMID:1003240. |
thirty-seven untreated parkinsonism patients showed significant positive correlations among decreased excretion of free dopamine, mmpi scores indicative of schizophrenic-like looseness of thinking, and the severity of all parkinsonism signs except tremor. |
1977-02-16 |
2023-08-11 |
Not clear |
| W W Baker, D Zivanovic, R T Malsee. Tremorogenic effects of intracaudate d-amphetamine and their suppression by dopamine. Archives internationales de pharmacodynamie et de therapie. vol 223. issue 2. 1977-01-28. PMID:999410. |
effects of d-amphetamine (15 mug) and dopamine (15-90 mug): d-amphetamine further increased the intensity of ongoing tremors induced by physostigmine (111 mug i.c. |
1977-01-28 |
2023-08-11 |
Not clear |
| W W Baker, D Zivanovic, R T Malsee. Tremorogenic effects of intracaudate d-amphetamine and their suppression by dopamine. Archives internationales de pharmacodynamie et de therapie. vol 223. issue 2. 1977-01-28. PMID:999410. |
dopamine was equally effective in suppressing d-amphetamine tremor activity. |
1977-01-28 |
2023-08-11 |
Not clear |
| E M Sellers, S D Cooper, D H Zilm, C Shank. Lithium treatment during alcoholic withdrawal. Clinical pharmacology and therapeutics. vol 20. issue 2. 1976-10-01. PMID:181193. |
lithium does not importantly alter patterns of catecholamine excretion, blood pressures, heart rate, serum cyclic-adenosine monophosphate (amp), serum dopamine beta-hydroxylase (dbh), sleep pattern, or tremor amplitude during withdrawal. |
1976-10-01 |
2023-08-11 |
Not clear |